ketanserin has been researched along with Pneumonia, Pneumococcal in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Pneumonia, Pneumococcal: A febrile disease caused by STREPTOCOCCUS PNEUMONIAE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spronk, PE | 1 |
| Rommes, JH | 1 |
| Schaar, C | 1 |
| Ince, C | 1 |
1 other study available for ketanserin and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
Thrombolysis in fulminant purpura: observations on changes in microcirculatory perfusion during successful treatment.
Topics: Ear; Fibrinolytic Agents; Humans; IgA Vasculitis; Ketanserin; Male; Microcirculation; Middle Aged; N | 2006 |